Metabolomics and Biomarkers for Drug Discovery
Metabolomics and biomarkers are increasingly used in drug discovery and development, and are applied to personalized medicine. Progress in these research areas has increased our understanding of disease pathology and improved therapeutic strategies for many diseases with unmet challenges. Further ad...
Main Author: | Pollen K. Yeung |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-01-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | http://www.mdpi.com/2218-1989/8/1/11 |
Similar Items
-
Metabolomics in drug discovery: Restoring antibiotic pipeline
by: Faiza Azhar, et al.
Published: (2023-01-01) -
Plant Metabolomics: The Future of Anticancer Drug Discovery
by: Ranin Dabbousy, et al.
Published: (2024-09-01) -
Editorial: Therapeutic and Diagnosis Target Discovery Based on Metabolomics
by: Linsheng Liu
Published: (2022-04-01) -
Current Status of Metabolomic Biomarker Discovery: Impact of Study Design and Demographic Characteristics
by: Vladimir Tolstikov, et al.
Published: (2020-05-01) -
Editorial: Pharmacometabolomics: biomarker discovery, precision medicine, technical advances, perspectives and future applications in respiratory diseases
by: Alessia Vignoli, et al.
Published: (2023-08-01)